Physician profile
Amit Prasad
NPI 1104036185
$7,263.93
in general payments reported to CMS, 2019-2025
39 companies · $2,314 in 2025
The $2,314 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $627 · 2021: $917 · 2022: $1,018 · 2023: $845 · 2024: $1,100 · 2025: $2,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,403 · Travel and Lodging: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,402.81 |
| Travel and Lodging | $856.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,189.67 | 2021-2025 | Micra |
| Merck Sharp & Dohme LLC | $614.34 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $592.26 | 2019-2025 | |
| Pfizer INC. | $542.80 | 2019-2025 | |
| Abbott Laboratories | $438.12 | 2019-2025 | Esprit, Diamondback Coronary, Xience Skypoint |
| Abiomed | $437.55 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $298.80 | 2020-2025 | Farxiga, Andexxa |
| Sanofi-Aventis U.S. LLC | $262.56 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $237.07 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $233.02 | 2019-2025 | Watchman Flx, Varithena Administration Pack |
| Cook Medical LLC | $218.74 | 2019-2023 | Zilver Ptx |
| Amgen INC. | $217.94 | 2019-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $196.19 | 2024-2025 | |
| Amarin Pharma, INC. | $172.35 | 2019-2021 | |
| Esperion Therapeutics, INC. | $170.34 | 2020-2023 | Nexletol |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $166.77 | 2022-2023 | Arcalyst |
| Medtronic Vascular, INC. | $138.78 | 2019-2020 | |
| Cardiovascular Systems INC. | $127.32 | 2021 | |
| Chiesi USA, INC. | $126.49 | 2024 | Kengreal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.14 | 2019-2025 | Jardiance |
| Philips North America LLC | $105.92 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, Event, Labosys |
| E.R. Squibb & Sons, L.L.C. | $84.68 | 2019-2025 | Camzyos, Eliquis |
| Kowa Pharmaceuticals America, INC. | $75.33 | 2020-2022 | |
| Angiodynamics, INC. | $61.52 | 2021-2022 | |
| Shockwave Medical, INC | $56.16 | 2025 | |
| Novo Nordisk INC | $50.40 | 2025 | Wegovy, Ozempic |
| Avinger INC. | $48.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $40.69 | 2021-2025 | Onpattro |
| Cardinal Health 200 LLC | $40.20 | 2020-2021 | |
| Terumo Medical Corporation | $34.26 | 2024 | Angio-Seal, Heartrail, Glidewire |
| Convatec INC. | $31.42 | 2025 | |
| Daiichi Sankyo INC. | $29.13 | 2023 | Injectafer |
| W. L. Gore & Associates, INC. | $27.20 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Glaxosmithkline, LLC. | $20.12 | 2025 | Shingrix, Arexvy |
| Regeneron Healthcare Solutions, INC. | $14.71 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.40 | 2025 | Assure Wcd |
| Surmodics, INC. | $14.19 | 2022 | |
| G Medical Diagnostic Services, INC. | $13.79 | 2023 | Cardiac Monitoring Suite |
| Zoll Circulation INC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.